Hamilelikte cannabidiol - derived from extract or tincture or resin of cannabis kullanmaktan kaçınmalı mıyım? | VeriMom

What to use instead

Pregnancy-safe ingredients that serve a similar function:

FAQ

cannabidiol - derived from extract or tincture or resin of cannabis hamilelikte güvenli mi?

There are multiple animal studies showing developmental and reproductive effects (rodent and zebrafish developmental toxicity, decreased pup survival and long-term behavioural/metabolic effects) and regulatory scrutiny by SCCS. CBD has been shown to affect developmental pathways in animals and is under active safety review for cosmetic use in the EU (SCCS preliminary opinion). Although a harmonised EU CLP Category 1 (H360) is not established, the weight of animal evidence and existing H361 self-notifications justify 'suspected' reproductive hazard (h=2) and a demonstrated mechanistic concern (m=2). Topical cosmetic exposure is generally low but measurable (e=1). (Sources: SCCS preliminary opinion; multiple peer‑reviewed developmental/reproductive animal studies; ECHA submissions/SDS noting H361.)

cannabidiol - derived from extract or tincture or resin of cannabis emzirirken güvenli mi?

CBD has been detected in human breast milk and professional guidance (Pediatrics/FDA commentary) recommends caution because data on nursing women using CBD/Epidiolex are limited. Animal developmental effects plus documented milk transfer support suspected hazard (h=2) and demonstrated exposure pathway (m=2). For topical cosmetic use maternal systemic exposure is likely low but measurable, so infant exposure via milk is possible though expected to be low from topical use (e=1).

cannabidiol - derived from extract or tincture or resin of cannabis bebek cildi için güvenli mi?

Infant skin has higher absorption per body weight; CBD shows biological activity in developmental models. Per scoring rules, increase exposure score by +1 for 0–3 y olds when adult absorption is measurable, giving e=2. Hazard remains 'suspected' based on animal developmental/reproductive data and regulatory concern (h=2) but infant-specific mechanistic data are limited (m=2 reflects demonstrated developmental/endocrine‑relevant activity in models).

VeriMom cannabidiol - derived from extract or tincture or resin of cannabis nasıl puanlıyor?

VeriMom cannabidiol - derived from extract or tincture or resin of cannabis'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 20/100 (yüksek risk) olarak puanlar.

Hamilelikte cannabidiol - derived from extract or tincture or resin of cannabis yerine neler kullanılabilir?

Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.